DKSH : Full-Year Results 2021 presentation

Full Year Results 2021

Media and Investor Conference

February 9, 2022

Delivering Growth - in Asia and Beyond.

Agenda

1. Highlights Full-Year 2021
2. Business Units Review
3. Financial Update
4. Outlook

Page 2

DKSH ‒ Continued Value Creation for Stakeholders

Delivering growth and value creation in Asia and beyond.

Page 3

FY 2021 - All Key Figures Above Last Year

Net Sales

(in CHF billion)

+5.4%1
10.7	11.1
FY 2020	FY 2021

EBIT2

(in CHF million)

+10.5%
	284.6
257.5	1.2
	283.4
FY 2020	FY 2021

Profit after tax3

(in CHF million)

+39.6%
	230.1
164.8
FY 2020	FY 2021

EPS

(in CHF)

+42.6%
	3.45
2.42
FY 2020	FY 2021

RONOC

(in percent)

+170bps
18.1%	19.8%
FY 2020	FY 2021

Free Cash Flow

(in CHF million)

+24.5%
	261.6
210.2
FY 2020	FY 2021

Strong results in a volatile environment

1 Constant exchange rates (CER): 2021 figures converted at 2020 exchange rates

2 Incl. gain on sale to aCommerce (CHF 10.3 million) and non-recurring share of loss in associate (CHF -9.1 million). Excluding these items, EBIT grew by 10.1% to CHF 283.4 millionPage 4 3 Incl. revaluation gain of aCommerce (2021: CHF 34.8 million; 2020: CHF 9.6 million). Excl. these items, profit after tax grew by 25.1% to CHF 194.1 million

M&A an additional growth driver

Seven acquisitions in 2021

South Korea

- Bosung (TEC)

China

- RBC (PM)

Spain

- HTBA (PM)

Singapore

- MedWorkz (HEC)

Australia

• Hahn Healthcare (HEC)
• STP (CG)
• SACOA (PM)

Accelerated M&A execution with financial discipline

• Acquisitions across all four Business Units
• Further consolidation of the specialty chemical distribution industry in APAC and Europe
• Expansion into Australia and New Zealand
• Strong project pipeline

Acquisitions since 2017:

Page 5